These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 2829105

  • 1. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M, Hovi L, Siimes MA, Roivainen M, Hovi T.
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [Abstract] [Full Text] [Related]

  • 2. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC, Modlin JF.
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [Abstract] [Full Text] [Related]

  • 3. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P, Ramon Bravo J, Andrus JK, Comellas MM, Galindo MA, de Quadros CA, Bell E.
    Bull World Health Organ; 1994 Aug; 72(2):221-5. PubMed ID: 8205641
    [Abstract] [Full Text] [Related]

  • 4. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001 Aug; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 5. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J.
    Dev Biol Stand; 1979 Aug; 43():151-7. PubMed ID: 230106
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM, Manor Y, Sofer D, Swartz T, Mendelson E.
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidemiological surveillance and control of poliomyelitis in the Republic of Cuba.
    Ochoa EG, Lago PM.
    J Hyg Epidemiol Microbiol Immunol; 1987 May; 31(4):381-9. PubMed ID: 2828465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE, Abed Y, Marcus O, Gerichter CB, Melnick JL.
    Dev Biol Stand; 1986 May; 65():137-43. PubMed ID: 3556771
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM.
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands.
    Oostvogel PM, Rumke HC, Conyn-Van Spaendonck MA, van der Avoort HG, Leeuwenburg J, van Loon AM.
    J Infect Dis; 2001 Dec 01; 184(11):1451-5. PubMed ID: 11709788
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M, Takizawa T, Nakayama T, Matsuura K, Yoshida H, Hasegawa S, Obara M, Horimoto E, Kurata T, Horie H.
    Scand J Infect Dis; 2008 Dec 01; 40(3):247-53. PubMed ID: 17907043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.